ライフサイエンスコーパス: tracer

1 he systematic review included 39 studies (11 tracers).

2 th the acid-mediated [(64)Cu]Cu-c[E(4)W(5)C] tracer.

3 ore for ratiometry, and acts as an endocytic tracer.

4 safety and tolerability of this new tau PET tracer.

5 wn by using [(11)C]PBR28 as a representative tracer.

6 te of streptavidin-peroxidase (Strep-HRP) as tracer.

7 that vanadate was a sensitive and useful Pi tracer.

8 an-magnetic nanoparticles (Suc-CS@MNPs) as a tracer.

9 opomer and HDO production using a deuterated tracer.

10 ng a platform strategy based on the original tracer.

11 , and SUV(max) of each organ system for both tracers.

12 ctivities preclude them as individual robust tracers.

13 )F-PSMA-1007 against 3 renally excreted PSMA tracers.

14 ith (13) C-bicarbonate and (15) N-leucine as tracers.

15 was chosen as the appropriate model for both tracers.

16 c resonance (NMR) non-invasively and without tracers.

17 tive radiation doses of other (68)Ga-labeled tracers.

18 roCT) and histology with fluorescent dextran tracers.

19 isotopes of methane, and several combustion tracers.

20 have already been proposed as promising PET tracers.

21 through competitive binding with fluorescent tracers.

22 ed with ICMS+ISOI and connections known from tracers.

23 and cons of (18)F-FDG and bacteria-targeting tracers.

24 onsiderable amounts of ionic and fluorescent tracers.

25 been limited by the unreliability of genetic tracers.

26 harmacophore in PSMA-targeted small-molecule tracers.

27 ocolloid with free indocyanine green used as tracers.

28 ently-labeled metabolites and macromolecular tracers.

29 We used stable and radioisotope tracers ((15) N, (33) P, (14) C) to quantify AMF-mediate

30 ed to quantify tumor uptake of the PD-L1 PET tracer (18)F-BMS-986192.

31 Conclusion: The tracer (18)F-JK-PSMA-7 was found to be safe and clinical

32 racteristics than the established (18)F-PSMA tracers (18)F-DCFPyL and (18)F-PSMA-1007.

33 Recently, the novel macrophage tracer [(18)F]fluoro-PEG-folate was developed.

34 : The novel synaptic vesicle glycoprotein 2A tracer, (18)F-SynVesT-1, displays excellent kinetic and

35 n preclinical trials, the recently developed tracer 2-methoxy-(18)F-DCFPyL ((18)F-JK-prostate-specifi

36 al injections of dextran-biotin (anterograde tracer; 20% in saline, 50-100 nl) were made into L3-L5 d

37 e positron-emission tomography (PET) imaging tracer 3'-deoxy-3'-fluorothymidine (FLT) from its impuri

38 fter intravenous injection of 100 MBq of the tracer, 4 successive PET/CT scans were obtained at 30, 6

39 When DFOB was added first, tracer (57)Fe remained in solution.

40 The fate of added tracer (57)Fe(II) was strongly dependent on the order of

41 binding assays were performed for the novel tracer (64)Cu-CuCB-bicyclam.

42 the effective radiation doses from the novel tracer (68)Ga-NODAGA-exendin-4 are very low for adults a

43 ent) were imaged with the CXCR4-directed PET tracer (68)Ga-pentixafor.

44 of PET scans with (18)F-FDG and other (18)F tracers; (68)Ga-FAPI-74 is comparable to other (68)Ga li

45 ere we present BAcTrace (Botulinum-Activated Tracer), a genetically encoded, retrograde, transsynapti

46 The tracer accumulates dose-dependently in GLP-1R-positive t

47 The tracer accumulates in CHL-GLP-1R xenografts.

48 The tracer accumulates specifically in the pancreatic islets

49 ts with brain pathologies revealed that slow tracer accumulation characterizes areas surrounding the

50 In all reference lesions, constant tracer accumulation was observed between 30 and 90 min a

51 o enable high-resolution spatial analysis of tracer accumulation.

52 Tracer activity in the pancreas, kidneys, duodenum, and

53 T imaging was performed after intraprostatic tracer administration of either indocyanine green (ICG)-

54 subsequent PET/MRI (149.8 +/- 49.7 min after tracer administration).

55 Animals were euthanized and imaged 1 h after tracer administration.

56 for FAPI PET/CT imaging even at 10 min after tracer administration.

57 le in serum, with more than 90% being intact tracer after 1 h.

58 We present a novel near-infrared FFA tracer, AlexaFFA, that is suitable for in vivo quantific

59 We developed a new tracer, an (18)F-labeled difluoro-analog of UCB-J ((18)F

60 Even though all tracer analogs allowed tumor identification with SPECT a

61 iotracers, for example, (99m)Tc-labeled PSMA tracer analogs for radioguided surgery.

62 123)I-, (124)I-, and (131)I-trametinib, pure tracer analogs to trametinib, were synthesized in more t

63 in humans by using positional isotopomer NMR tracer analysis.

64 e bone collagen can be used as a geolocation tracer and for palaeoenvironmental studies such as traci

65 nutrients are convenient sources of isotope tracers and are commonly added as supplements to a varie

66 ruct simultaneously the trajectories of flow tracers and calanoid copepods and we quantify their abil

67 Utilization of (13)C isotope tracers and dynamic metabolomics documented that 5-PAHSA

68 ent of crossed projections using anterograde tracers and electron microscopy to explore the maturatio

69 We present a novel series of radioiodinated tracers and potential theranostics for diseases accompan

70 trol on the macroscopic transport of charged tracers and reactants.

71 We use correlations of tracers and tracer ratios to provide new perspectives on

72 rable to those known for most of the (99m)Tc tracers and was lower than for the (68)Ga-labeled and (1

73 meters, including known shale OG geochemical tracers, and microbial and benthic macroinvertebrate com

74 h (18)F-fluorodeoxyglucose, PET with amyloid tracers, and MRI.

75 sed magnetic resonance imaging, radiolabeled tracers, and multiphoton imaging in rodents to show inst

76 atmosphere in field settings where exogenous tracer applications are challenging.

77 gal composition and plant uptake of a (15) N tracer applied at the permafrost boundary.

78 Viral tracers are important tools for neuroanatomical mapping

79 More selective inflammatory tracers are requisite to identify the diffuse local infl

80 he differential extravasation of fluorescent tracers as a biomarker.

81 In the present study, fluorescent and ionic tracers, as well as microcomputed tomography, were used

82 meability to individually injected exogenous tracers-as is standard in BBB studies-fully represents b

83 f Rac1, diffusion of cytoplasmic rheological tracers at a volumetric rate of 14 Hz, and large field o

84 re analyzed to determine the total number of tracer-avid lesions, organ systems of involvement, and S

85 ht scattering, small-angle x-ray scattering, tracer-based microrheology, and neutron spin echo spectr

86 levated concentrations of primary combustion tracers (BC and NO(x)) near 30% of metal recycling and c

87 o not need to be collected, and over passive tracers because the chattering dust delineates the trans

88 lines and caused up to a 12-fold increase in tracer binding.

89 The tracer binds to human CCR2.

90 Tissues were collected to evaluate ex vivo tracer biodistribution and to perform flow cytometric, W

91 The secondary aim was to depict the tracer biodistribution and tumor-to-background ratios (T

92 Ex vivo tracer biodistribution in immunocompetent BALB/cOlaHsd (

93 Tracer biodistribution was determined in BALB/c nude mic

94 and whole-body counts, to determine safety, tracer biodistribution, pharmacokinetics, and radiation

95 The tracer can discriminate a range of tumor cell PD-L1 memb

96 Tracers can help visualize the lymphatic drainage patter

97 SO(3))Cy5-mas(3)) yielded the most promising tracer candidate for imaging of PSMA.

98 The tracer cannot reliably differentiate non-Alzheimer tauop

99 itive multifunctional and multimodal imaging tracers, carbon-coated FeCo nanoparticles may confer adv

100 hen injected fluorescently tagged retrograde tracers (cholera toxin subunit B) into retinotopically-m

101 t late time points after injection may allow tracer clearance from normal tissue and hence improve im

102 of treatment because of the larger degree of tracer clearance in this early phase.

103 l products (FIVE-VCP) inventory, we identify tracer compounds for different VCP categories: decamethy

104 y (PET) radioligands (radioactively labelled tracer compounds) are extremely useful for in vivo chara

105 Summed concentrations of these tracers correlated with particulate sulfate spanning thr

106 he rat SN is supported by the mouse neuronal tracer data.

107 10 patients who were examined with both PSMA tracers demonstrated that (18)F-JK-PSMA-7 was at least e

108 tracers.IMPORTANCE Anterograde transneuronal tracers derived from herpes simplex virus 1 (HSV-1) stra

109 evaluating algorithms and exploring lineage tracer design principles.

110 ent(3-10) and non-Gaussian statistics of the tracer displacements(6,9,10).

111 In vitro, both tracers displayed preferential binding to activated hPBM

112 In addition, we studied tracer distribution and co-localization with macrophages

113 measurements to determine the time course of tracer distribution and facilitate radiation dose estima

114 ntravenous long-chain fatty acid and glucose tracers during a standard liquid meal in 12 obese subjec

115 d meningeal lymphangiogenesis (P = .035) and tracer dye uptake in the anterior and middle regions of

116 aracteristic rearrangement of stable isotope tracers (e.g., 13C or 15N) that can be detected by mass

117 in ALS, standardized analysis across these 2 tracers enables pooling of TSPO PET data across multiple

118 efore use yields FERM, a stable in vivo cell tracer, enabling whole-body (89)Zr PET and (19)F MRI aft

119 oncentrations and phenylalanine and tyrosine tracer enrichments from which whole-body and splanchnic

120 Although none of the tracers entered the leaf through the stomatal pores, sma

121 cancer and has stifled the adoption of other tracers, except in situations where low avidity or high

122 In nonhuman primates, both tracers exhibited faster kinetics than (11)C-GR103545 an

123 Isotope tracer experiments in humans and animals over several de

124 Isotopic oxygen tracer experiments support a Mars van Krevelen redox mec

125 A portion of the endocytic tracer FM4-64 is also recycled back to the PM after inte

126 ial perfusion imaging shows promise as a new tracer for CAD detection and assessment of women, obese

127 represents a promising new FR-beta-targeted tracer for imaging macrophage-associated inflammation.

128 -DOTA-Siglec-9, holds promise as a novel PET tracer for imaging of inflammation.

129 and [(11)C]-1R (CHDI-180R) is a suitable PET tracer for imaging of mHTT aggregates.

130 kin-2 ((18)F-FB-IL2) was introduced as a PET tracer for T cell imaging.

131 s to K(V)1 channels and can be used as a PET tracer for the detection of demyelinated lesions in rode

132 lusion: (99m)Tc-PHC-102 is a promising SPECT tracer for the imaging of patients with ccRCC.

133 Thus, REEs are sensitive tracers for evaluating the interaction of groundwater wi

134 To broaden the spectrum of applicable PET tracers for extended imaging studies of FAP-dependent di

135 erent cytotoxicity, can be radiolabeled with tracers for imaging and with beta- and alpha-emitter rad

136 , (99m)Tc-labeled FAPIs represent attractive tracers for imaging applications in a larger number of p

137 lyfluoroalkyl substances (PFAS) as potential tracers for OSPW.

138 ngth, 700-1,200 nm), making them suitable as tracers for photoacoustic imaging.

139 complexes as radiopharmaceuticals and (86)Y tracers for positron emission tomography (PET) imaging.

140 have been made to develop bacteria-targeting tracers for specific infection imaging, which include tr

141 veniently radiolabeled with carbon-11 as PET tracers for the in vivo imaging of an allosteric binding

142 Injections of the retrograde tracer fragment B of cholera toxin (CTb) were performed

143 Here, we followed the flow of various tracers from the external seawater to within the cells o

144 dditional SNs were resected (7 in the hybrid-tracer group and 15 in the free-ICG group).

145 ll SNs in only 40% of patients in the hybrid-tracer group and 20% of patients in the free-ICG group.

146 nine green (ICG)-(99m)Tc-nanocolloid (hybrid-tracer group) or (99m)Tc-nanocolloid to create a road ma

147 This tracer has the potential to identify primary and metasta

148 ate-specific membrane antigen (PSMA)-binding tracers have been shown to be promising agents for the s

149 Most of the tracers have been studied only in experimental animals,

150 or metastasized cancer, FAPI (FAP inhibitor) tracers have recently been used to study cardiac remodel

151 ons in 17 of the 25 patients, and the hybrid tracer ICG-(99m)Tc-nanocolloid was shown to outperform f

152 improvements of H129-based anterograde viral tracers.IMPORTANCE Anterograde transneuronal tracers der

153 There is also a significant role for this tracer in extending our knowledge on the role of beta-ce

154 istribution was favorable for testing of the tracer in larger group of patients with rheumatoid arthr

155 The diffusion process followed by a passive tracer in prototypical active media, such as suspensions

156 ng, can be used as a long-timescale sediment tracer in soils to reveal the structure of soil mixing.

157 rmed to detect the fluorescent signal of the tracer in the pancreas of mini pigs.

158 Localization of the tracer in the pancreatic islets of BALB/c nude mice was

159 umor growth was similarly inhibited by the 2 tracers in a dose-dependent manner.

160 Our measurements of these tracers in air around Los Angeles in 2015 reveal high va

161 the diagnostic accuracy of the different PET tracers in differentiating tumor progression from treatm

162 on protein-specific small-molecule inhibitor tracers in oncology will be discussed along with potenti

163 tau positivity (T+) for multiple tau-imaging tracers in order to reach a consensus on normal and abno

164 flux of other labeled tracers (such as (15)N-tracers) in any metabolite detectable by LC-MS/MS and in

165 med cell death ligand 1 (PD-L1) adnectin PET tracer, in patients with non-small cell lung cancer.

166 ein tracer, with (11)C-JNJ717, a novel P2X7R tracer, in vitro and in vivo in ALS.

167 ond-generation (99m)Tc-labeled PSMA-targeted tracer incorporating a fluorescent dye.

168 (SV-TAG) and filter samplers to measure SOA tracers indicative of isoprene/HO(2) (2-methyltetrols, C

169 Tracer influx assessed in coronal slices was increased i

170 Second, tracer-informed water flow models are improving predicti

171 BBB-impermeable fluorescent tracer injected transcardially to mice is selectively up

172 afferents were back-labeled using retrograde tracers injected into proximal and distal regions of col

173 ng extensively labeled by general retrograde tracers injected into the VTA.

174 Tracer injection and scanning were repeated 2 h after in

175 The analysis based on CSF tracer injection in combination with immunohistochemistr

176 ortex was mapped electrophysiologically, for tracer injection placement to determine S1 CST terminati

177 ce was performed at 15, 60, and 90 min after tracer injection.

178 rane-expressed PD-L1 as soon as 60 min after tracer injection.

179 2, 3, 6, and 24 h and SPECT/CT at 6 h after tracer injection.

180 endent virus injections in GAD2-Cre mice and tracer injections in GAD67-GFP mice, as well as immunocy

181 We identified the dopaminergic source using tracer injections in reticular nuclei, which retrogradel

182 Dopaminergic neurons labeled by tracer injections in the medOB were located in the OB, t

183 patterns of retrograde labeling result from tracer injections into different NTS subdivisions, with

184 a combination of retrograde and anterograde tracers into structures important for contextual memorie

185 synthesis to the final injectable formulated tracer is 70 min.

186 A (11)C-labeled tracer is always accompanied by a large excess of non-ra

187 8)F]F-HPA-12 in the brain suggested that the tracer is degraded less efficiently in the FAD mice.

188 Calculating radiation doses from this tracer is important to assess its safety for use in pati

189 The evidence for other tracers is limited; thus, (18)F-FET and (11)C-MET are pr

190 e assessment and comparison of other amyloid tracers, is warranted.

191 an almost perfect concordance between the 2 tracers (kappa ranged from 0.871 to 1).

192 and causes erroneous parameter estimates in tracer kinetic modeling in brain PET studies.

193 volume ratio (DVR) was estimated using full tracer kinetics (reversible 2-tissue-compartment [2TC] m

194 lume ratios (DVR) estimated from noninvasive tracer kinetics and SUV ratio (SUVR) measured at differe

195 ng high diagnostic performance and favorable tracer kinetics for potential therapeutic applications.

196 mpanied by a large excess of non-radioactive tracer known as carrier.

197 ecause of the favorable half-life of (64)Cu, tracers labeled with this PET nuclide could solve logist

198 ively transporting as shown by phloem-mobile tracers, lacked nacreous walls and exhibited open lumina

199 More specifically, when using hybrid tracers, lesions can be noninvasively identified and loc

200 y combining depth-specific sampling with age tracer modeling, particle tracking simulations, geologic

201 We performed a pressure and chemical tracer monitoring experiment at the site of an undergrou

202 We developed a unique lineage tracer mouse model exploiting the T(RM)-defining transcr

203 are (15)N(15)N isotopologue of N(2) as a new tracer of air contamination in volcanic gas effusions.

204 or specific infection imaging, which include tracers of bacterial maltodextrin transporter, bacterial

205 However, personal care products as direct tracers of human domestic habits are often overlooked.

206 .6) x 10(10) joules-have been interpreted as tracers of moist convection originating near the 5-bar l

207 am water concentrations of known geochemical tracers of OG extraction, and the composition of benthic

208 d with fluorine-18 and used as surrogate PET tracers of TD139 and GB1107.

209 sity of OG development, shale OG geochemical tracers, or benthic macroinvertebrate or microbial commu

210 ro)organisms, analytical platforms, isotopic tracers, or classes of metabolites.

211 We track a single tracer particle within a slowly densifying glass and mea

212 el family of selective MMP-12 inhibitors and tracers, paving the way for further development of these

213 tively predict the distribution of an inulin tracer perfused through the multi-organ human-body-on-ch

214 Pharmacology and tracer permeability rule out coupling by gap junctions a

215 Previously obtained results with macrophage tracer (R)-[(11)C]PK11195 were encouraging, but the imag

216 d ratios as compared to reference macrophage tracer (R)-[(11)C]PK11195.

217 We use correlations of tracers and tracer ratios to provide new perspectives on sulfate, NO

218 Results: For both tracers, regional time-activity curves were fitted well

219 re generated to highlight areas of increased tracer retention compared to cognitively normal controls

220 emporal lobar degeneration showed a range of tracer retention that was less than Alzheimer's disease,

221 Both tracers revealed a considerable number of areas of uptak

222 In vivo, all tracers revealed uptake in activated hPBMCs in SCID mice

223 This tracer showed excellent targeting of the folate receptor

224 Conclusion: The 2 novel KOR agonist tracers showed faster tissue kinetics than (11)C-GR10354

225 Both tracers showed good in vitro and in vivo characteristics

226 Both PET tracers showed high stability and specificity in vitro a

227 on: (18)F-FET and (11)C-MET, both amino-acid tracers, showed a comparably higher sensitivity than (18

228 Here, we demonstrate that a pH-sensitive PET tracer specifically detects acidosis in regions associat

229 eful for nuclear forensics and environmental tracer studies.

230 We used natural tracers such as (14) C to investigate the age and source

231 protocol, or the use of lower-energy imaging tracers such as (18)F-PSMA, is required to reduce false-

232 re lower than reported for other polypeptide tracers such as somatostatin analogs (2.1-2.6 mSv/100 MB

233 y adapted to track the flux of other labeled tracers (such as (15)N-tracers) in any metabolite detect

234 el near-infrared (NIR) free fatty acid (FFA) tracer suitable for in vivo imaging of deep tissues such

235 acid conjugated folate ((18)F-FOL) is a PET tracer targeting folate receptor beta (FR-beta), which i

236 ements, chemical water quality data, and dye tracer tests provide evidence of human fecal contaminati

237 (18)F-PI-2620 is a next-generation tau PET tracer that has demonstrated ability to image the spatia

238 ere is a strong rationale for the use of PET tracers that can monitor T-cell activation and expansion

239 rs were synthesized with a passive inorganic tracer to aid in faster and more quantitative analysis u

240 ate kinetic model to quantify binding of the tracer to M1 receptors, and the reliability of the chose

241 Specific binding of the tracer to MMP-12 was demonstrated through ex vivo compet

242 e for selective anterograde transport of the tracer to nerve terminal endings in bone, the periosteum

243 The ability of this tracer to quantify CD8(+) T-cell tumor infiltrates was e

244 ial use of (89)Zr-HDL nanoparticles as a PET tracer to quickly monitor the response to CSF1R inhibito

245 is rising trend, remarkable decreases of the tracers track the major socioeconomic crises that occurr

246 atively low estimate of the rate constant of tracer trapping, suggesting that the 1-compartment model

247 Based on data from previous (15) N-tracer trials, Yan et al.

248 or three reasons: (a) higher yield in (15) N tracer trials; (b) a low residue return rate is assumed;

249 ) (-) contributed 39% to 90% to total (15) N tracer uptake among four plantations during the study pe

250 Importantly, the linear correlation between tracer uptake and beta-cell area was maintained in spite

251 normalization of BG levels restored absolute tracer uptake and GLP-1R expression in beta-cells and th

252 Detailed mapping of the tracer uptake and insulin and GLP-1R expression conclusi

253 Increased (68)Ga-PSMA-11 tracer uptake and intratumoral retention correlate with

254 Tracer uptake and PSMA expression were compared between

255 es by enabling noninvasive quantification of tracer uptake as a measure for beta-cell mass.

256 demonstrated that the observed reduction in tracer uptake directly correlates to GLP-1R expression l

257 Tracer uptake in AAAs that subsequently ruptured (SUV=1.

258 Lastly, dynamic scanning demonstrated fast tracer uptake in affected joints, reaching a plateau aft

259 asymmetry index (AI) was calculated between tracer uptake in both hemispheres.

260 mbrane levels in tumor cell lines, and tumor tracer uptake in mice was associated with PD-L1 expressi

261 Pretreatment with letrozole reduced tracer uptake in most subjects, although the percentage

262 found between the number of visual auras and tracer uptake in occipital PMT.

263 in PSMA uptake, the intrinsic variability of tracer uptake in PCa lesions needs to be defined.

264 ated quantification of tissue morphology and tracer uptake in PET/MR images could streamline the anal

265 All PCa patients showed high tracer uptake in primary and metastatic lesions with T/M

266 ak stages (Braak I-IV) did not show elevated tracer uptake in these regions compared to young, tau-ne

267 ection techniques that would enable absolute tracer uptake quantification.

268 Tracer uptake was determined as the maximal SUV (SUV(max

269 Tracer uptake was expressed as percentage injected dose

270 Results: Tracer uptake was highest in the striatum, followed by n

271 age of 24 regions per subject with increased tracer uptake was identified, and an average of 20 regio

272 Tracer uptake was quantified using maximum tissue-to-bac

273 The tracer uptake was reduced to less than 5% when cells wer

274 tribution volume is confined to tissues with tracer uptake, potentially limiting SUV quantification.

275 vation in brain regions containing increased tracer uptake.

276 al regions of interest (ROIs) with increased tracer uptake.

277 vanadate was tested as a possible foliar Pi tracer using high-resolution laser ablation-inductively

278 The tracer was also able to selectively displace the CXCR4 a

279 th femoral arteriovenous balance and glucose tracer was applied after the control and hypercaloric di

280 Tracer was found in regional lymph nodes in 100% of pati

281 of 78 hours, only a single administration of tracer was needed to obtain all four PET/CT scans.

282 Results: The highest uptake of FAPI tracer was observed in liver metastases and anal cancer,

283 On average, 2% of recovered tracer was present in the placenta and 6% was found in t

284 Glymphatic influx of a CSF tracer was significantly enhanced at 30 d postsurgery in

285 era toxin which is a monosynaptic retrograde tracer was used as a control to be able to differentiate

286 human programmed cell death ligand 1 (PD-L1) tracer, was developed to noninvasively determine whole-b

287 The 2 PSMA tracers were administered to each patient less than 3 wk

288 ly anterograde polysynaptic and monosynaptic tracers were developed from H129 and have been applied f

289 Retrograde neural tracers were injected in different parts of the putamen

290 Both tracers were stable in serum, with more than 90% being i

291 om both eyes, studied with the transneuronal tracer WGA-HRP, are intermixed in the binocular zone of

292 s provide further evidence that the anti-CD8 tracer, which is currently in clinical phase II, is a pr

293 ped that replaces the ubiquitous fluorescent tracer with an electroactive one.

294 (18)F-PI-2620 is a PET tracer with high binding affinity for aggregated tau, a

295 onfirmed noninterference of the anti-CD8-PET-tracer with the mode of action of CEA-TCB/CEA-4-1BBL and

296 ific uptake was determined by coinjection of tracer with unlabeled IL2 and by evaluating uptake in a

297 tly applied anterograde and retrograde viral tracers with practical guidance on experimental uses.

298 14, a second-generation translocator protein tracer, with (11)C-JNJ717, a novel P2X7R tracer, in vitr

299 However, it is currently unknown which tracer yields the best results.

300 e whether imaging with the HER2-targeted PET tracer zirconium 89 ((89)Zr)-pertuzumab can depict HER2-